NEW YORK – Hologic reported after the close of the market on Wednesday that revenues for its first quarter of fiscal year 2021 surged 89 percent year over year, driven by sales of its diagnostic testing products for SARS-CoV-2.
NEW YORK – Hologic reported after the close of the market on Wednesday that revenues for its first quarter of fiscal year 2021 surged 89 percent year over year, driven by sales of its diagnostic testing products for SARS-CoV-2.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.